Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.
Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications.
复制标题
DOI:
10.1016/j.hoc.2013.01.002
复制
发表时间:
2013-04
影响因子:
2.4
通讯作者:
Wiestner, Adrian
中科院分区:
文献类型:
--
作者:
Herishanu, Yair;Katz, Ben-Zion;Lipsky, Andrew;Wiestner, Adrian
Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. An often indolent lymphoproliferative disorder, CLL is characterized by the progressive accumulation of monoclonal, small, mature-appearing CD5+ B-cells in the peripheral blood, bone marrow and secondary lymphoid organs.[1] With the notable exception of allogeneic stem cell transplantation, CLL is currently an incurable disease, despite the fact that good initial responses to chemoimmunotherapy are obtained, which prolong overall survival.[2] Current treatment modalities appear to eradicate malignant CLL cells less efficiently in the bone marrow and lymph nodes than in peripheral blood. Thus, patients who initially achieve a remission will eventually develop recurrent disease. Moreover, the differential response of the disease in different anatomic locations indicates a significant role of the tissue microenvironment in supporting CLL cell survival and enabling them to evade the toxic effects of chemotherapy.Recent work has demonstrated that the trafficking, survival and proliferation of CLL cells is tightly regulated by the surrounding tissue microenvironment (Figure 1). This conclusion is bolstered by several lines of evidence. When cultured in vitro, CLL cells rapidly undergo apoptosis, but they can be temporarily rescued from programmed cell death by contact with stromal cells. Stromal cells are also known to confer a protective effect against chemotherapy-induced apoptosis.[3, 4] Additionally, there are differences in the characteristics of CLL cells in the various tissue compartments. CLL cells in the peripheral blood are arrested in G0/G1 phase of the cell cycle [5] and display features that are consistent with a defect in programmed cell death and prolonged in vivo survival [1]. Previously, this observation was thought to suggest that CLL is a malignancy of quiescent non-proliferating cells. However, recent data on telomere length [6] and in vivo measurement of CLL cell kinetics demonstrated that CLL cells exhibit a more prominent turnover than
登录
查看更多内容
影响因子:
64.5
作者:
Brunet, A;Bonni, A;Greenberg, ME
通讯作者:
Greenberg, ME
DOI:
10.1158/1078-0432.ccr-10-2879
发表时间:
2011-05-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Amrein PC;Attar EC;Takvorian T;Hochberg EP;Ballen KK;Leahy KM;Fisher DC;Lacasce AS;Jacobsen ED;Armand P;Hasserjian RP;Werner L;Neuberg D;Brown JR
通讯作者:
Brown JR
影响因子:
20.3
作者:
Bagnara, Davide;Kaufman, Matthew S.;Chiorazzi, Nicholas
通讯作者:
Chiorazzi, Nicholas
DOI:
10.3324/haematol.2009.005835
发表时间:
2009-09-01
期刊:
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL
影响因子:
--
作者:
Aue, Georg;Njuguna, Ndegwa;Wiestner, Adrian
通讯作者:
Wiestner, Adrian
影响因子:
20.3
作者:
Buerkle, Andrea;Niedermeier, Matthias;Burger, Jan A.
通讯作者:
Burger, Jan A.